Stryker

Stryker raises full-year guidance despite muted investor reaction

Stryker’s MedSurg and Neurotechnology unit saw sales rise 17.3% year-over-year to $3.8 billion. Orthopedics, meanwhile, generated $2.2 billion in revenue, up just 2.0%.